Physician profile
Luba Frank
NPI 1780690586
$3,667.16
in general payments reported to CMS, 2019-2025
8 companies · $421 in 2025
The $421 reported for 2025 was more than what 77% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $76.07 · 2022: $55.16 · 2023: $776 · 2024: $1,591 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513 · Travel and Lodging: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,513.18 |
| Travel and Lodging | $275.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $2,433.83 | 2022-2025 | Ffrct |
| Ge Healthcare | $700.09 | 2019-2020 | |
| Cleerly, INC. | $179.61 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Bard Peripheral Vascular, INC. | $157.67 | 2024 | Venovo, Venclose Maven Catheter |
| Siemens Medical Solutions USA, INC. | $123.28 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $29.94 | 2024 | Opsumit, Uptravi |
| Bridgebio Pharma, INC. | $25.83 | 2025 | Attruby |
| Pfizer INC. | $16.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luba Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.